Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer

Published:2020-08 Issue:8 Volume:38 Page:684.e17-684.e24
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Fujita Naoki,Hatakeyama Shingo,Momota Masaki,Kido Koichi,Narita Takuma,Tobisawa Yuki,Yoneyama Tohru^ORCID,Yamamoto Hayato,Imai Atsushi,Ito Hiroyuki,Yoneyama Takahiro,Hashimoto Yasuhiro,Yoshikawa Kazuaki,Ohyama Chikara

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference23 articles.

1. Predictive biomarkers for drug response in bladder cancer;Yoshida;Int J Urol,2019

2. Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: a web-based survey;Choo;Int J Urol,2019

3. Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naive stage T1 high-grade urothelial bladder cancer;Otto;Int J Urol,2018

4. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline;Chang;J Urol,2017

5. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update;Babjuk;Eur Urol,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is lipophilicity the main factor determining the effective drug penetration through lipid membranes? Combined GIXD and PM-IRRAS studies on the example of anthracyclines;Journal of Molecular Liquids;2023-09

2. Effects of intravenous chemotherapy after TURBT for high-risk nonmuscle invasive bladder cancer: results of a retrospective study;Journal of Cancer Research and Clinical Oncology;2023-08-04

3. Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer;PLOS ONE;2023-02-10

4. Genitourinary Cancer: Updates on Treatments and Their Impact on the Kidney;Seminars in Nephrology;2022-11

5. Comparative efficacy of intravesical perfusion therapy in non-muscle invasive bladder cancer : A systematic review and network meta-analysis;2022-08-24